Compugen reported $2.97M in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.97M 58K Jun/2025
Life Technologies USD 1.84M 416K Jun/2025
RedHill Biopharma USD 356K 202K Dec/2024